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Background
Immediate hypersensitivity reactions to food are a major
health concern for Canadians due to severity of reac-
tions they elicit and their increasing prevalence. Cur-
rently 6% of children develop food allergy. Peanut (PN)
hypersensitivity is one of the major causes of food-
related anaphylaxis. We tested the hypothesis that the
route of initial exposure to food antigen dictates the
nature of the immune response and hence the develop-
ment of an allergic response/anaphylaxis vs.t o l e r a n c e
upon subsequent or secondary exposure. The aim of
this study was to: 1) establish three independent animal
models of peanut exposure via the oral, dermal and
inhalational routes that will allow us to 2) investigate
whether sensitization or tolerance develops following
gastrointestinal, dermal or inhalational exposures, fol-
lowing initial exposures via the alternate route.
Methods
Female Balb/c mice (8-weeks old) were sensitized to 1
mg of PN protein in combination with 5 μgc h o l e r a
toxin as an adjuvant or PBS on days 0 and 14 via the
oral, dermal or intranasal routes; and challenged with
crude peanut extract (CPE) by oral gavage (2 mg), der-
mally (10 μg) or intranasally (500 μg) on days 28, 30, 32,
35, 37 and 39. Mice were assessed for allergy/anaphy-
laxis (i.e., rectal temperature at 10 minute intervals,
scoring for clinical symptoms of anaphylaxis) for 40
minutes after the last allergen challenge and then eutha-
nized for: 1) general (e.g., measurement of PN-specific
immunoglobulins, plasma histamine and inflammatory
cell infiltration into the target organ), and 2) route-spe-
cific end-points (i.e., measurement of wheal diameter
and pulmonary function testing using the flexiVent after
dermal and nasal challenge, respectively). A previously
established murine model of peanut anaphylaxis was
used as the positive control [1]. Data are expressed as
the mean ± SEM (n = 12-16/group).
Results
Oral sensitization followed by oral challenge evoked the
most clinically potent allergic reaction, as compared
with dermal or nasal challenge (mean clinical scores of
1.7 ± 0.1, 1.0 ± 0.3 and 0.06 ± 0.04, respectively). To
investigate peanut-specific humoral immune response
we measured serum IgE and IgG subclass levels. Intra-
gastric sensitization with peanut extract induced a sig-
nificant IgE response (125.9 ± 21.7 ng/mL), whereas
nasal or cutaneous priming favored elevated levels of
the IgG subclasses. Higher IgG1/G2a ratios (10-25 folds
within the cross sensitization/challenge groups) indi-
cated Th2 polarization of the immune response. PN
sensitization and challenge by all three routes resulted
in similar increases of plasma histamine upon secondary
challenge. Oral or nasal priming triggered greater
inflammatory cell infiltration in the peritoneal cavity
upon oral challenge. Dermal and nasal priming prefer-
entially resulted in more severe skin inflammation as
assessed by wheal diameter, compared with orally-sensi-
tized animals. Upon inhalational challenge, orally-sensi-
tized mice exhibited greater cellular infiltration into the
airways with predominantly neutrophilic influx, whereas
nasal sensitization favored mild eosinophilia in the BAL.
However, PN priming via these routes and subsequent
challenge did not affect methacholine responsiveness of
the airways.
Conclusions
Our observations indicate that 1) oral sensitization is the
most likely to elicit a significant allergic response to
peanut upon secondary challenge, dermal sensitization is
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© 2010 Khanna and Scott; licensee BioMed Central Ltd.less likely; nasal sensitization results in an intermediate
likelihood. 2) Oral sensitization resulted in higher pro-
duction of allergen-specific IgE antibodies, whereas
nasal or cutaneous sensitization induced greater IgG
responses; higher IgG1/G2a ratios point to Th2 biased
response. 3) Initial exposure via the oral route triggered
neutrophilia, while inhalational priming elicited an eosi-
nophilic influx into the target organs. Comparison of
the immune and cellular mediators of tolerance and
anaphylaxis via the different routes may help to identify
the causative mediator/cell population that could lead to
novel therapeutic targets for intervention.
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